National Bowel Cancer Screening Program 2019
Aims to reduce the morbidity and mortality from bowel cancer by actively screening for early detection or prevention of the disease.
In 2019, it is estimated that about 8,000 people aged 50–74 will be diagnosed with bowel cancer (approximately 49% of all bowel cancers diagnosed) and 2,000 people aged 50–74 will die from bowel cancer (approximately 35% of all bowel cancer deaths).
Of the 4.1 million people invited between January 2016 and December 2017, 41% participated in the program. The national participation rate was the same as for the previous rolling 2-year period (2015–2016) (41%). The re-participation rate for people who had taken part in their previous invitation round and were receiving a subsequent screening invitation was 78%.
In 2017, about 69,000 Australians returned a positive screening test, giving an 8% screening positivity rate. Of the people who received a positive screening test, 66% had reported a follow-up diagnostic assessment. The median time from positive screening test result to diagnostic assessment was 52 days.
Cancers and adenomas detected
As form return is not mandatory, diagnostic assessment data were not considered complete enough to allow formal performance indicator reporting. However, of the data available for participants who had a diagnostic assessment in 2017, 1 in 29 were diagnosed with a confirmed or suspected cancer (266 and 1,318, respectively) and adenomas were diagnosed in a further 5,237 participants (1 in 9 participants assessed). Adenomas are benign growths that have the potential to become cancerous; their removal lowers the risk of future bowel cancers in these participants.
Participants who identified as being of Aboriginal or Torres Strait Islander origin, lived in Very remote areas, and those who lived in low socioeconomic areas all had higher rates of positive screens (warranting further assessment), but had lower rates of follow-up diagnostic assessment, and a longer median time between a positive screen and assessment.
Since the NBCSP began
Since the program began in August 2006, about 5.5 million NBCSP screening tests have been completed, with about 280,000 participants having a diagnostic assessment to follow up a positive screening result. From the data available for participants who have had diagnostic assessment, 1 in 29 have been diagnosed with a confirmed or suspected cancer and 1 in 8 have had an adenoma detected. Previous data linkage studies by the Australian Institute of Health and Welfare found that the NBCSP is contributing to reducing morbidity and mortality from bowel cancer in Australia (AIHW 2014a, 2018a, 2018c).
Read National Bowel Cancer Screening Program 2019 report.